Protein kinase C-θ (PKCθ): It's all about location, location, location

Immunological Reviews

Volumn 192, Issue , 2003, Pages 53-63

  Altman, Amnon ^a   Villalba, Martin ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD28 ANTIGEN; DIACYLGLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PHOSPHOLIPASE C; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; CELL MATURATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CYTOSKELETON; DIGLYCERIDES; HUMANS; ISOENZYMES; MEMBRANE MICRODOMAINS; MICE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE C; T-LYMPHOCYTES;

EID: 0037902559     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2003.00027.x     Document Type: Review

References (98)

1. Truneh A, Alvert F, Golstein P, Schmitt-Verhulst AM. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbolester. Nature 1985;313:318-320.
2. Isakov N, Altman A. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes. J Immunol 1985;135:3674-3680.
3. Nishizuka Y. A new possible regulatory system for protein phosphorylation in human peripheral lymphocytes. II. Possible relation to phosphatidylinositol turnover induced by mitogens. J Immunol 1981;127:1375-1383.
4. Altman A, Coggeshall KM, Mustelin T. Molecular events mediating T cell activation. Adv Immunol 1990;48:227-360.
5. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
6. Baier G, et al. Molecular cloning and characterization of PKCθ, a human novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 1993;268:4997-5004.
7. Chang JD, Xu Y, Raychowdhury MK, Ware JA. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J Biol Chem 1993;268:14208-14214.
8. Osada S, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S. A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle. Mol Cell Biol 1992;12:3930-3938.
9. Altman A, Isakov N, Baier G. PKCθ, a new essential superstar on the T cell stage. Immunol Today 2000;21:567-573.
10. Arendt CW, Albrecht B, Soos TJ, Littman DR. Protein kinase C-θ. signaling from the center of the T-cell synapse. Curr Opin Immunol 2002;14:323-330.
11. Isakov N, Altman A. Protein kinase C-θ in T cell activation. Annu Rev Immunol 2002;20:761-794.
12. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-246.
13. Baier-Bitterlich G, et al. PKCθ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 1996;16:1842-1850.
14. Avraham A, Jung S, Samuels Y, Seger R, Nen-Neriah Y. Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur J Immunol 1998;28:2320-2330.
15. Werlen G, Jacinto E, Xia Y, Karin M. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes. EMBO J 1998;17:3101-3111.
16. Ghaffari-Tabrizi N, Bauer B, Altman A, Utermarm G, Uberall F, Baier G. Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T-cells. Eur J Immunol 1999;29:132-142.
17. Sun Z, et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 2000;404:402-407.
18. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol 1997;15:707-747.
19. Coudronniere N, Villalba M, Englund N, Altman A. NF-κB activation reduced by CD28 costimulation is mediated by PKCθ. Proc Nad Acad Sci USA 2000;97:3394-3399.
20. Lin X, O'Mahony A, Geleziunas R, Greene WC. Protein kinase C θ participates in NF-κB/Rel activation induced by CDB/CD28 costimulation through selective activation of IκB β (IKKβ). Mol Cell Biol 2000;20:2933-2940.
21. Shapiro VS, Truitt KE, Imboden JB, Weiss A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol Cell Biol 1997;17:4051-4058.
22. McGuire KL, Iacobelli M. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J Immunol 1997;159:1319-1327.
23. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221-227.
24. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular clusters in T cells. Nature 1998;395:82-86.
25. Wülfing C, Davis MM. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998;282:2266-2269.
26. Penninger JM, Crabtree GR. The actin cytoskeleton and lymphocyte activation. Cell 1999;96:9-12.
27. Horejsi V, et al. GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today 1999;20:356-361.
28. Xavier R, Seed B. Membrane compartmentation and the response to antigen. Curr Opin Immunol 1999;11:265-269.
29. Dustin ML, Chan AC. Signaling takes shape in the immune system. Cell 2000;103:283-294.
30. Monks CRF, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-θ during T-cell activation. Nature 1997;385:83-86.
31. Bi K, et al. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation. Nature Immunol 2001;2:556-563.
32. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 1995;268:247-251.
33. Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol 1997;9:161-167.
34. Huang J, et al. CD28 plays a critical role in the segregation of PKC θ within the immunologic synapse. Proc Natl Acad Sci USA 2002;99:9369-9373.
35. Villalba M, Coudronniere N, Deckert M, Teixeiro E, Mas P, Altman A. Functional interactions between Vav and PKCθ are required for TCR-induced T cell activation. Immunity 2000;12:151-160.
36. Schneider H, Cai YC, Cefai D, Raab M, Rudd CE. Mechanisms of CD28 signalling. Res Immunol 1995;146:149-154.
37. Szallasi Z, Bogi K, Gohari S, Biro T, Acs P, Blumberg PM. Non-equivalent roles for the first and second zinc fingers of protein kinase Cδ. Effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells. J Biol Chem 1996;271:18299-18301.
38. Medkova M, Cho W. Interplay of C1 and C2 domains of protein kinase C-α in its membrane binding and activation. J Biol Chem 1999;274:19852-19861.
39. Villalba M, Bi K, Rpdriguez F, Tanaka Y, Schoenberger S, Altman A. Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J Cell Biol 2001;155:331-338.
40. Meller N, et al. Direct interaction between protein kinase C θ (PKC-θ) and 14-3-3τ in T cells, 14-3-3 overexpression results in inhibition of PKC-θ translocation and function. Mol Cell Biol 1996;16:5782-5791.
41. Collins T, Deckert M, Altman A. Views cn Vav. Immunol Today 1997;18:221-225
42. Fischer KD, et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol 1998;8:554-562.
43. Holsinger LJ, et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 1998;8:563-572.
44. Kong YY, et al. Vav regulates peptide-specific apoptosis in thymocytes. Exp Med 1998;188:2099-2111.
45. Hehner SP, Li-Weber M, Giaisi M, Droge W, Krammer PH, Schmitz ML. Vav synergizes with protein kinase Cθ to mediate IL-4 gene expression in response to CD28 costimulation in T cells. J Immunol 2000;164:3829-3836.
46. Villalba M, et al. Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol 2002;157:253-263.
47. Yang WC, Collette Y, Nunes JA, Olive D. Tec kinases: a family vdth multiple roles in immunity. Immunity 2000;12:373-382.
48. Chou MM, et al. Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Curr Biol 1998;8:1069-1077.
49. Dutil EM, Toker A, Newton AC. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr Biol 1998;8:1366-1375.
50. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-2045.
51. Sonnenburg ED, Gao T, Newton AC. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 2001;276:45289-45297.
52. Parekh DB, Ziegler W, Parker PJ, Multiple pathways control protein kinase C phosphorylation. EMBO J 2000;19:496-503.
53. Toker A, Newton AC. Cellular signaling: pivoting around PDK-1. Cell 2000;103:185-188.
54. Liu Y, Witte S, Liu Y-C, Doyle M, Elly C, Altman A. Regulation of PKCθ function during T cell activation by Lck-mediated tyrosine phosphorylation. J Biol Chem 2000;275:3603-3609.
55. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr Biol 1999;9:601-604.
56. H2 cytokines. Nature Immunol 2001;2:37-44.
57. Bauer B, et al. Complex formation and cooperation of PKCθ and Akt1/PKBα in the transactivation of the IKKβ/I-κBα/NF-κB signaling cascade in T cells. J Biol Chem 2001;176:31627-31634.
58. Lin X, Cunningham ETJ, Mu Y, Geleziunas R, Greene WC. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 1999;10:271-280.
59. Kempiak SJ, Hiura TS, Nel AE. The Jun kinase cascade is responsible for activating the CD28RE element of the IL-2 promoter: proof of cross-talk with the IκB kinase cascade. J Immunol 1999;162:3176-3187.
60. Patriotis C, Makris A, Chernoff J, Tsichlis PN. Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase Proc Natl Acad Sci USA 1994;91:9755-9759.
61. Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 1996;15:817-826.
62. Ballester A, Tobena R, Lisbona C, Calvo V, Alemany S. Cot kinase regulation of IL-2 production in Jurkat T cells. J Immunol 1997;159:1613-1618.
63. Tsatsanis T, Patriotis C, Baer SE, Tsichlis PN. The tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc Natl Acad Sci USA 1998;95:3827-3832.
64. Tsatsanis C, Patriotis C, Tsichlis PN. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κB. Oncogene 1998;17:2609-2618.
65. Dumitru CD, et al. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000;103:1071-1083.
66. Ruland J, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube dosure. Cell 2001;104:33-42.
67. Bertin J, et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB. J Biol Chem 2001;276:11877-11882.
68. Gaide O, Martinon F, Michean O, Bonnet D, Thome M, Tschopp J. Carma 1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation. FEBS Lett 2001;496:121-127.
69. Gaide O, et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nature Immunol 2002;3:836-843.
70. Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex. EMBO J 2002;21:5184-5194.
71. Wang D, et al. A requirement for CARMA1 TCR-induced NF-κB activation. Nature Immunol 2002;3:830-835.
72. Craven SE, Bredt DS. PDZ proteins organize synaptic signaling pathways. Cell 1998;93:495-498.
73. Fanning AS, Anderson JM. PDZ domains, fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999;103:767-772.
74. Garner CC, Nash J, Huganir RL. PDZ domains in synapse assembly and signaling. Trends Cell Biol 2000;10:274-280.
75. Khoshnan A, Bae D, Tidell CA, Nel AE. The physical association of protein kinase CO with a lipid raft-associated inhibitor of κB factor kinase (IKK) complex plays a role in the activation of the NF-κB cascade by TCR and CD28. J Immunol 2000;165:6933-6940.
76. Derijard B, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-1037.
77. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994;77:727-736.
78. Han J, Jiang Y, Kravchenko W, Ulevitch RJ. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997;386:296-299.
79. Coso OA, et al. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novd c-jun amino-terminal kinase-independent pathway. J Biol Chem 1997;272:20691-20697.
80. Shin HM, Han TH. CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells. Mol Immunol 1999;36:197-203.
81. Swanson BJ, Jack HM, Lyons GE. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. Mol Immunol 1998;35:445-458.
82. Forbes IJ, Zalewski PD, Giannakis C, Cowled PA. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 1992;198:367-372.
83. Illera VA, Perandones CE, Stunz LL, Mower DA Jr, Ashman RF. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 1993;151:2965-2973.
84. Rodriguez-Tarduchy G, Lopez-Rivas A. Phorbol esters inhibit apoptosis in IL-2-dependent T lymphocytes. Biochem Biophys Res Commun 1989;164:1069-1075.
85. Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 1995;2:353-362.
86. Zhou T, Song L, Yang P, Wang Z, Lui D, Jope RS. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nature Med 1999;5:42-48.
87. Boise LH, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995;3:87-98.
88. Bertolotto C, Maulon L, Filippa N, Baier G, Auberger P. PKC-θ and ε promote T cell survival by a Rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem 2000;275:37246-37250.
89. Villalba M, Bushway P, Altman A. PKCθ mediates a selective T cell survival signal via phosphorylation of BAD. J Immunol 2001;166:5955-5963.
90. Villalba M, Altman A. Protein kinase C-θ (PKCθ), an example of a drug target for therapeutic intervention with human T cell leukemias. Curr Cancer Drug Targets 2002;2:125-134.
91. Heray F, Boisteau O, Bretaudeau L, Lieubeau B, Meflah K, Gregoire M Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res 1999;59:3329-3332.
92. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
93. Budworth J, Gant TW, Gescher A. Co-ordinate loss of protein kinase C and multidrug resistance gene expression revertant MCF-7/Adr breast carcinoma cells. Br J Cancer 1997;75:1330-1335.
94. Beck J, et al. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 1996;10:426-433.
95. Gill PK, Gescher A, Gant TW. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and θ. Eur J Biochem 2001;268:4151-4157.
96. Ebinu JO, et al. RasGRP links T-cell receptor signaling to Ras. Blood 2000;95:3199-3203.
97. Powell JD, Ragheb JA, Kitagawa-Sakakida S, Schwartz RH. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 1998;165:287-300.
98. Chambers CA, Allison JP. Costimulatory regulation of T cell function. Curr Opin Cell Biol 1999;11:203-210.